Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$105,000.00
Enhancing human pluripotent stem cell differentiation to pancreatic progenitors by control of endogenous cell signalling
EF 2011-12
Résumé
Type 1 diabetes mellitus, formerly juvenile diabetes, is a health condition caused by a lack of insulin, a hormone that lowers blood glucose. Patients with type 1 diabetes mellitus cannot produce insulin because their immune system has destroyed insulin-secreting beta cells in the pancreas. In the absence of insulin, their blood glucose rises, causing dysfunction in the eye, kidney, nervous system, heart, and circulatory system. These health problems represent a significant burden on both patients and the Canadian health care system. There is currently no cure for type 1 diabetes mellitus, and patients have an average 15 year reduction in life expectancy.
Insulin injections are currently used to replace insulin the body normally synthesizes, but even the most diligent patient will eventually experience complications related to higher than normal blood glucose. Transplantation of insulin-secreting beta cells from cadaver donors can restore normal insulin and blood glucose regulation, but there are too few donors to meet demand for cells. A possible solution to the limited numbers of insulin-secreting beta cells for transplantation is the creation of large amounts of these cells from human pluripotent stem cells. Human pluripotent stem cells can be converted, under the right conditions, to any type of cell in the body. My project will generate insulin-secreting beta cells from human pluripotent stem cells capable of treating type 1 diabetes mellitus. This approach has the potential to increase the quality of life for patients with type 1 diabetes mellitus and reduce the demand on the Canadian health care system.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
257572
Name
Woodford Curtis M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Enhancing human pluripotent stem cell differentiation to pancreatic progenitors by control of endogenous cell signalling
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Co-Culture; Diabetes; Embryonic Stem Cells; Endoderm; Endothelial Cells; Insulin-Secreting Cell; Pancreas; Regenerative Medicine; Tissue Engineering; Transplant
Abstract
Type 1 diabetes mellitus, formerly juvenile diabetes, is a health condition caused by a lack of insulin, a hormone that lowers blood glucose. Patients with type 1 diabetes mellitus cannot produce insulin because their immune system has destroyed insulin-secreting beta cells in the pancreas. In the absence of insulin, their blood glucose rises, causing dysfunction in the eye, kidney, nervous system, heart, and circulatory system. These health problems represent a significant burden on both patients and the Canadian health care system. There is currently no cure for type 1 diabetes mellitus, and patients have an average 15 year reduction in life expectancy.
Insulin injections are currently used to replace insulin the body normally synthesizes, but even the most diligent patient will eventually experience complications related to higher than normal blood glucose. Transplantation of insulin-secreting beta cells from cadaver donors can restore normal insulin and blood glucose regulation, but there are too few donors to meet demand for cells. A possible solution to the limited numbers of insulin-secreting beta cells for transplantation is the creation of large amounts of these cells from human pluripotent stem cells. Human pluripotent stem cells can be converted, under the right conditions, to any type of cell in the body. My project will generate insulin-secreting beta cells from human pluripotent stem cells capable of treating type 1 diabetes mellitus. This approach has the potential to increase the quality of life for patients with type 1 diabetes mellitus and reduce the demand on the Canadian health care system.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Woodford, Curtis M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~